首页> 外国专利> CTLA4 IG fusion protein to regulate Cellular interactions and immune responses.

CTLA4 IG fusion protein to regulate Cellular interactions and immune responses.

机译:CTLA4 IG融合蛋白可调节细胞相互作用和免疫应答。

摘要

As a ligand for the receptor CTLA4 Antigen B7. Provides the complete amino acid sequence of Human CTLA4 encodes The receptor gene.Methods are provided for expressing a fusion protein of CTLA4 and immunoglobulin fusion protein to prepare to use Hybrid CTLA4 and soluble fusion proteins.Fragments and Derivatives thereof, including Monoclonal Antibodies that REACT with B7 and CTLA4,For regular Interactions with T cells and immune responses mediated by these interactions.Claims: 1) ctla4ig fusion protein that binds to the Antigen B7Taking the first amino acid sequence of a Protein consisting of the extracellular domain of CTLA4 and a Second Amino Acid Sequence that consists of the axisThe CH2 and CH3 regions of the Molecule of a human immunoglobulin.2) a ctla4ig fusion protein that binds to the Antigen B7(a) a Protein having the Amino Acid Sequence that starts with the first amino acid alanine at position 1 and ending with the Aspartic acid at amino acid position of the 125 SEQ id no: 13 represents the CTLA4 extracellular domain and (b) a Second Amino Acid Sequence that consists of the Axis, and the CH2 and CH3 regions of a Molecule of human immunoglobulin.
机译:作为受体CTLA4抗原B7的配体。提供人类CTLA4编码受体基因的完整氨基酸序列。提供了表达CTLA4和免疫球蛋白融合蛋白的融合蛋白的方法,以制备使用杂交CTLA4和可溶性融合蛋白的方法。其片段和衍生物,包括与REACT结合的单克隆抗体B7和CTLA4,用于与T细胞的常规相互作用以及由这些相互作用介导的免疫反应。声明:1)与抗原B7结合的ctla4ig融合蛋白以蛋白的第一个氨基酸序列为由CTLA4的胞外域和第二个氨基酸组成由轴组成的酸序列人免疫球蛋白分子的CH2和CH3区域.2)与抗原B7(a)结合的ctla4ig融合蛋白,该蛋白的氨基酸序列以第一个氨基酸丙氨酸开始于125 SEQ ID no:13的氨基酸位置1处并以天冬氨酸结尾的序列表示CTLA4细胞外结构域,并且(b)第二个氨基酸序列,由人免疫球蛋白分子的轴和CH2和CH3区域组成。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号